Table 2.

PASC related outcomes between COVID-19 patients with or without a HIV positive diagnosis (HIV+, HIV-) after propensity score matching.

Outcome	HIV+	HIV-	OR (95% CI)	p-Value
Mortality	441 (3.3%)	364 (2.8%)	1.22 (1.06, 1.40)	0.006
Hypertension	453 (7.3%)	383 (6.2%)	1.18 (1.03, 1.36)	0.019
Diabetes	333 (3.3%)	300 (3.0%)	1.11 (0.95, 1.3)	0.199
Thyroid Disorders	117 (1.0%)	110 (0.9%)	1.06 (0.82, 1.38)	0.646
Heart Disease	525 (6.0%)	415 (4.5%)	1.35 (1.18, 1.54)	<0.001
Malignancy	249 (2.2%)	173 (1.5%)	1.49 (1.22, 1.81)	<0.001
Thrombosis	339 (3.1%)	301 (2.7%)	1.16 (0.99, 1.35)	0.072
Mental Disorders	476 (8.6%)	491 (5.5%)	1.62 (1.42, 1.85)	<0.001
Rheumatoid Arthritis	23 (0.2%)	21 (0.2%)	1.09 (0.6, 1.97)	0.770
Respiratory Symptoms	3444 (26.1%)	2641 (20.0%)	1.41 (1.33, 1.5)	<0.001
Headache	1271 (9.6%)	789 (6.0%)	1.68 (1.53, 1.84)	<0.001
Fatigue	1756 (13.3%)	1351 (10.2%)	1.35 (1.25, 1.45)	<0.001
Bodyache	617 (4.7%)	443 (3.4%)	1.41 (1.25, 1.6)	<0.001
Diarrhea/constipation	2169 (16.4%)	1262 (9.6%)	1.86 (1.73, 2)	<0.001
Cognitive Impairment	140 (1.1%)	98 (0.7%)	1.43 (1.11, 1.86)	0.006
Disturbances to Smell and Taste	74 (0.6%)	52 (0.4%)	1.43 (1, 2.03)	0.049
Fatigue	1298 (9.8%)	973 (7.4%)	1.37 (1.26, 1.49)	<0.001
Chronic cough	1674 (12.7%)	1088 (8.2%)	1.62 (1.49, 1.75)	<0.001
Brain Fog	326 (2.5%)	209 (1.6%)	1.57 (1.32, 1.88)	<0.001
Palpitations	415 (3.1%)	454 (3.4%)	0.91 (0.8, 1.04)	0.179
Chest pain	2228 (16.9%)	1668 (12.6%)	1.4 (1.31, 1.5)	<0.001
Sexual desire or capacity	35 (0.3%)	22 (0.2%)	1.59 (0.93, 2.72)	0.085
Dizziness	922 (7.0%)	693 (5.2%)	1.36 (1.22, 1.5)	<0.001
Gastrointestinal	3851 (29.1%)	2656 (20.1%)	1.64 (1.54, 1.73)	<0.001
Hair loss	150 (1.1%)	125 (0.9%)	1.2 (0.95, 1.53)	0.130
Abnormal movements	327 (2.5%)	271 (2.1%)	1.21 (1.03, 1.43)	0.021